The STEP 1 trial, published in the New England Journal of Medicine, showed that participants taking 2.4mg of semaglutide lost an average of 14.9% of their body weight over 68 weeks, significantly more than the placebo group
And if you want something light, nonmilky, and fruit-forward, protein waters can be a great middle ground, as they are often easier to sip slowly, when thicker shakes feel too heavy
Your treatment plan is tailored to your health profile, ensuring you receive the most effective care
Ozempic is also a GLP-1 receptor agonist, which is FDA-approved for managing type 2 diabetes, reducing the risk of cardiovascular diseases, and preventing kidney failure in patients with chronic kidney disease and type 2 diabetes